Chorea Diagnosis: Understanding the Evaluation Process

Chorea — brief, irregular, flowing, non-repetitive involuntary movements — is a clinical sign, not a diagnosis. Its etiology is broad.

Major Etiologies

  • Genetic: Huntington disease (HD) — CAG repeat in HTT; autosomal dominant. Onset 30s–40s; chorea + cognitive/psychiatric decline.
  • Autoimmune/post-infectious: Sydenham chorea (post-GAS, rheumatic fever); anti-NMDA receptor encephalitis; SLE (chorea gravidarum).
  • Drug-induced: Dopamine blockers (antipsychotics — tardive dyskinesia), levodopa (peak-dose chorea), stimulants, oral contraceptives, anticonvulsants.
  • Metabolic/endocrine: Hyper/hypothyroidism, hyper/hypoglycemia, hyperparathyroidism.
  • Structural/vascular: Stroke (hemichorea-hemiballismus — contralateral subthalamic nucleus), tumor, trauma.
  • Paraneoplastic: Anti-CRMP5, anti-Hu, etc.
  • Other genetic: Wilson disease, neuroacanthocytosis, benign hereditary chorea.

Diagnostic Workup

  1. Detailed history: Onset, progression, medications, family history, pregnancy, systemic symptoms.
  2. Neurologic exam: Characterize movements (chorea vs. ballism, dystonia, tics, myoclonus); assess cognition, behavior, eye movements, gait.
  3. Lab studies: CBC, CMP, TSH, copper/ceruloplasmin, lipid panel, HIV, RPR, ANA, ESR/CRP, CK, vitamin B12/folate, thyroid antibodies, paraneoplastic panel.
  4. Brain MRI: Atrophy (caudate in HD), signal changes (stroke, tumor, Wilson's), basal ganglia lesions.
  5. Genetic testing: HTT CAG repeat (HD); gene panels for other hereditary choreas.
  6. EEG/LP: If encephalitis suspected (autoimmune, infectious).

Treatment

Target underlying cause. Symptomatic: VMAT2 inhibitors (deutetrabenazine, valbenazine), dopamine blockers (risperidone, olanzapine), tetrabenazine. Discontinue offending drugs if possible.

Bunions - Related Articles